nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrofolic acid—Methotrexate—urinary bladder cancer	0.359	1	CrCtD
Tetrahydrofolic acid—MTHFR—urinary bladder cancer	0.145	1	CbGaD
Tetrahydrofolic acid—ATIC—Methotrexate—urinary bladder cancer	0.0613	0.365	CbGbCtD
Tetrahydrofolic acid—Raltitrexed—Methotrexate—urinary bladder cancer	0.0474	0.2	CrCrCtD
Tetrahydrofolic acid—Leucovorin—Methotrexate—urinary bladder cancer	0.0474	0.2	CrCrCtD
Tetrahydrofolic acid—Folic Acid—Methotrexate—urinary bladder cancer	0.0474	0.2	CrCrCtD
Tetrahydrofolic acid—Pralatrexate—Methotrexate—urinary bladder cancer	0.0474	0.2	CrCrCtD
Tetrahydrofolic acid—Pemetrexed—Methotrexate—urinary bladder cancer	0.0474	0.2	CrCrCtD
Tetrahydrofolic acid—MTHFR—Fluorouracil—urinary bladder cancer	0.0462	0.275	CbGbCtD
Tetrahydrofolic acid—MTHFR—Methotrexate—urinary bladder cancer	0.0255	0.151	CbGbCtD
Tetrahydrofolic acid—ABCC2—Carboplatin—urinary bladder cancer	0.00921	0.0548	CbGbCtD
Tetrahydrofolic acid—ABCC2—Cisplatin—urinary bladder cancer	0.00787	0.0468	CbGbCtD
Tetrahydrofolic acid—ABCC2—Etoposide—urinary bladder cancer	0.00773	0.046	CbGbCtD
Tetrahydrofolic acid—ABCC2—Doxorubicin—urinary bladder cancer	0.00527	0.0314	CbGbCtD
Tetrahydrofolic acid—ABCC2—Methotrexate—urinary bladder cancer	0.00511	0.0304	CbGbCtD
Tetrahydrofolic acid—FTCD—prostate gland—urinary bladder cancer	0.00177	0.0516	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—prostate gland—urinary bladder cancer	0.00121	0.0353	CbGeAlD
Tetrahydrofolic acid—FTCD—renal system—urinary bladder cancer	0.00121	0.0351	CbGeAlD
Tetrahydrofolic acid—MTFMT—prostate gland—urinary bladder cancer	0.00112	0.0326	CbGeAlD
Tetrahydrofolic acid—AMT—prostate gland—urinary bladder cancer	0.00099	0.0288	CbGeAlD
Tetrahydrofolic acid—MTFMT—seminal vesicle—urinary bladder cancer	0.000948	0.0276	CbGeAlD
Tetrahydrofolic acid—MTHFD1—prostate gland—urinary bladder cancer	0.000947	0.0276	CbGeAlD
Tetrahydrofolic acid—MTHFD2—female reproductive system—urinary bladder cancer	0.000839	0.0244	CbGeAlD
Tetrahydrofolic acid—AMT—seminal vesicle—urinary bladder cancer	0.000837	0.0244	CbGeAlD
Tetrahydrofolic acid—Pralatrexate—SLC19A1—urinary bladder cancer	0.000835	0.332	CrCbGaD
Tetrahydrofolic acid—ALDH1L1—renal system—urinary bladder cancer	0.000828	0.0241	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—urethra—urinary bladder cancer	0.000813	0.0237	CbGeAlD
Tetrahydrofolic acid—MTHFD1—seminal vesicle—urinary bladder cancer	0.000801	0.0233	CbGeAlD
Tetrahydrofolic acid—SHMT2—prostate gland—urinary bladder cancer	0.000801	0.0233	CbGeAlD
Tetrahydrofolic acid—MTFMT—urethra—urinary bladder cancer	0.00075	0.0218	CbGeAlD
Tetrahydrofolic acid—SHMT1—prostate gland—urinary bladder cancer	0.000729	0.0212	CbGeAlD
Tetrahydrofolic acid—ATIC—prostate gland—urinary bladder cancer	0.000686	0.02	CbGeAlD
Tetrahydrofolic acid—AMT—renal system—urinary bladder cancer	0.000675	0.0196	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—female reproductive system—urinary bladder cancer	0.000663	0.0193	CbGeAlD
Tetrahydrofolic acid—AMT—urethra—urinary bladder cancer	0.000663	0.0193	CbGeAlD
Tetrahydrofolic acid—MTHFD1—renal system—urinary bladder cancer	0.000646	0.0188	CbGeAlD
Tetrahydrofolic acid—MTHFD1—urethra—urinary bladder cancer	0.000634	0.0185	CbGeAlD
Tetrahydrofolic acid—SHMT1—seminal vesicle—urinary bladder cancer	0.000617	0.0179	CbGeAlD
Tetrahydrofolic acid—MTFMT—female reproductive system—urinary bladder cancer	0.000612	0.0178	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—vagina—urinary bladder cancer	0.0006	0.0174	CbGeAlD
Tetrahydrofolic acid—MTR—prostate gland—urinary bladder cancer	0.00058	0.0169	CbGeAlD
Tetrahydrofolic acid—MTFMT—vagina—urinary bladder cancer	0.000553	0.0161	CbGeAlD
Tetrahydrofolic acid—SHMT2—renal system—urinary bladder cancer	0.000546	0.0159	CbGeAlD
Tetrahydrofolic acid—AMT—female reproductive system—urinary bladder cancer	0.00054	0.0157	CbGeAlD
Tetrahydrofolic acid—MTHFD1—female reproductive system—urinary bladder cancer	0.000517	0.015	CbGeAlD
Tetrahydrofolic acid—MTHFR—prostate gland—urinary bladder cancer	0.00051	0.0148	CbGeAlD
Tetrahydrofolic acid—ATIC—epithelium—urinary bladder cancer	0.000504	0.0147	CbGeAlD
Tetrahydrofolic acid—SHMT1—renal system—urinary bladder cancer	0.000497	0.0145	CbGeAlD
Tetrahydrofolic acid—MTR—seminal vesicle—urinary bladder cancer	0.000491	0.0143	CbGeAlD
Tetrahydrofolic acid—AMT—vagina—urinary bladder cancer	0.000489	0.0142	CbGeAlD
Tetrahydrofolic acid—SHMT1—urethra—urinary bladder cancer	0.000488	0.0142	CbGeAlD
Tetrahydrofolic acid—ATIC—smooth muscle tissue—urinary bladder cancer	0.000486	0.0141	CbGeAlD
Tetrahydrofolic acid—ATIC—renal system—urinary bladder cancer	0.000468	0.0136	CbGeAlD
Tetrahydrofolic acid—MTHFD1—vagina—urinary bladder cancer	0.000468	0.0136	CbGeAlD
Tetrahydrofolic acid—SHMT2—female reproductive system—urinary bladder cancer	0.000437	0.0127	CbGeAlD
Tetrahydrofolic acid—SHMT1—female reproductive system—urinary bladder cancer	0.000398	0.0116	CbGeAlD
Tetrahydrofolic acid—MTR—renal system—urinary bladder cancer	0.000396	0.0115	CbGeAlD
Tetrahydrofolic acid—SHMT2—vagina—urinary bladder cancer	0.000395	0.0115	CbGeAlD
Tetrahydrofolic acid—MTR—urethra—urinary bladder cancer	0.000389	0.0113	CbGeAlD
Tetrahydrofolic acid—ALDH1L1—lymph node—urinary bladder cancer	0.000388	0.0113	CbGeAlD
Tetrahydrofolic acid—ATIC—female reproductive system—urinary bladder cancer	0.000375	0.0109	CbGeAlD
Tetrahydrofolic acid—Methotrexate—SLC19A1—urinary bladder cancer	0.000368	0.146	CrCbGaD
Tetrahydrofolic acid—SHMT1—vagina—urinary bladder cancer	0.00036	0.0105	CbGeAlD
Tetrahydrofolic acid—SHMT1—Podofilox—Etoposide—urinary bladder cancer	0.000359	0.241	CbGdCrCtD
Tetrahydrofolic acid—MTFMT—lymph node—urinary bladder cancer	0.000358	0.0104	CbGeAlD
Tetrahydrofolic acid—Raltitrexed—TYMS—urinary bladder cancer	0.00032	0.127	CrCbGaD
Tetrahydrofolic acid—MTR—female reproductive system—urinary bladder cancer	0.000317	0.00922	CbGeAlD
Tetrahydrofolic acid—AMT—lymph node—urinary bladder cancer	0.000316	0.0092	CbGeAlD
Tetrahydrofolic acid—MTHFD1—Podofilox—Etoposide—urinary bladder cancer	0.00031	0.208	CbGdCrCtD
Tetrahydrofolic acid—ABCC2—prostate gland—urinary bladder cancer	0.000305	0.00888	CbGeAlD
Tetrahydrofolic acid—MTHFD1—lymph node—urinary bladder cancer	0.000302	0.0088	CbGeAlD
Tetrahydrofolic acid—MTR—vagina—urinary bladder cancer	0.000287	0.00834	CbGeAlD
Tetrahydrofolic acid—MTHFR—female reproductive system—urinary bladder cancer	0.000278	0.0081	CbGeAlD
Tetrahydrofolic acid—SHMT2—lymph node—urinary bladder cancer	0.000256	0.00744	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Doxorubicin—Valrubicin—urinary bladder cancer	0.000245	0.165	CbGdCrCtD
Tetrahydrofolic acid—MTHFD2—Epirubicin—Valrubicin—urinary bladder cancer	0.000245	0.165	CbGdCrCtD
Tetrahydrofolic acid—Pralatrexate—TYMS—urinary bladder cancer	0.000242	0.0963	CrCbGaD
Tetrahydrofolic acid—Leucovorin—TYMS—urinary bladder cancer	0.000242	0.0963	CrCbGaD
Tetrahydrofolic acid—SHMT1—lymph node—urinary bladder cancer	0.000233	0.00677	CbGeAlD
Tetrahydrofolic acid—ATIC—lymph node—urinary bladder cancer	0.000219	0.00638	CbGeAlD
Tetrahydrofolic acid—ABCC2—renal system—urinary bladder cancer	0.000208	0.00605	CbGeAlD
Tetrahydrofolic acid—Pemetrexed—TYMS—urinary bladder cancer	0.000194	0.077	CrCbGaD
Tetrahydrofolic acid—MTR—lymph node—urinary bladder cancer	0.000185	0.00539	CbGeAlD
Tetrahydrofolic acid—ABCC2—female reproductive system—urinary bladder cancer	0.000166	0.00484	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Podofilox—Etoposide—urinary bladder cancer	0.000164	0.11	CbGdCrCtD
Tetrahydrofolic acid—MTHFR—lymph node—urinary bladder cancer	0.000163	0.00474	CbGeAlD
Tetrahydrofolic acid—Folic Acid—MTHFR—urinary bladder cancer	0.000124	0.0493	CrCbGaD
Tetrahydrofolic acid—Methotrexate—TYMS—urinary bladder cancer	0.000107	0.0424	CrCbGaD
Tetrahydrofolic acid—ABCC2—lymph node—urinary bladder cancer	9.74e-05	0.00283	CbGeAlD
Tetrahydrofolic acid—MTHFD2—Doxorubicin—Epirubicin—urinary bladder cancer	8.53e-05	0.0574	CbGdCrCtD
Tetrahydrofolic acid—Methotrexate—MTHFR—urinary bladder cancer	8.5e-05	0.0338	CrCbGaD
Tetrahydrofolic acid—MTHFD2—Epirubicin—Doxorubicin—urinary bladder cancer	7.89e-05	0.0531	CbGdCrCtD
Tetrahydrofolic acid—MTR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	4.09e-05	0.000769	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	4.05e-05	0.000762	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Folate Metabolism—TP53—urinary bladder cancer	4.01e-05	0.000753	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—IL2—urinary bladder cancer	3.87e-05	0.000728	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—CYP4B1—urinary bladder cancer	3.81e-05	0.000717	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—TYMP—urinary bladder cancer	3.8e-05	0.000715	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—RRM2—urinary bladder cancer	3.71e-05	0.000698	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTZ1—urinary bladder cancer	3.7e-05	0.000696	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000677	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000659	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTO2—urinary bladder cancer	3.51e-05	0.000659	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NAT1—urinary bladder cancer	3.51e-05	0.000659	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Validated targets of C-MYC transcriptional activation—TP53—urinary bladder cancer	3.47e-05	0.000652	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Vitamin B12 Metabolism—TNF—urinary bladder cancer	3.46e-05	0.000651	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—TNF—urinary bladder cancer	3.44e-05	0.000648	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—NAT2—urinary bladder cancer	3.44e-05	0.000647	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—ENO2—urinary bladder cancer	3.44e-05	0.000647	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—HPGDS—urinary bladder cancer	3.44e-05	0.000647	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—urinary bladder cancer	3.35e-05	0.000629	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GSTT1—urinary bladder cancer	3.34e-05	0.000627	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	3.32e-05	0.000624	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—ENO2—urinary bladder cancer	3.28e-05	0.000617	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—SLC19A1—urinary bladder cancer	3.26e-05	0.000612	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—UGT2B7—urinary bladder cancer	3.21e-05	0.000603	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—PRSS3—urinary bladder cancer	3.17e-05	0.000597	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—GSTO2—urinary bladder cancer	3.17e-05	0.000597	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—RBX1—urinary bladder cancer	3.11e-05	0.000585	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Folate Metabolism—TP53—urinary bladder cancer	3.04e-05	0.000571	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—HDAC4—urinary bladder cancer	3.03e-05	0.000569	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—RRM2—urinary bladder cancer	2.97e-05	0.000558	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—CYP4B1—urinary bladder cancer	2.89e-05	0.000543	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—TNF—urinary bladder cancer	2.82e-05	0.00053	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTZ1—urinary bladder cancer	2.8e-05	0.000527	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—TYMP—urinary bladder cancer	2.8e-05	0.000527	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—JAG1—urinary bladder cancer	2.79e-05	0.000524	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—NQO1—urinary bladder cancer	2.77e-05	0.000521	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—ENO2—urinary bladder cancer	2.75e-05	0.000517	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—HPGDS—urinary bladder cancer	2.75e-05	0.000517	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Selenium Micronutrient Network—TNF—urinary bladder cancer	2.74e-05	0.000514	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—SLC19A1—urinary bladder cancer	2.73e-05	0.000513	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GSTT1—urinary bladder cancer	2.67e-05	0.000501	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTO2—urinary bladder cancer	2.66e-05	0.0005	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—PRSS3—urinary bladder cancer	2.66e-05	0.0005	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NAT1—urinary bladder cancer	2.66e-05	0.0005	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—NRF2 pathway—NQO1—urinary bladder cancer	2.61e-05	0.00049	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—GSTO2—urinary bladder cancer	2.6e-05	0.000488	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—NAT2—urinary bladder cancer	2.54e-05	0.000477	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Folate Metabolism—TP53—urinary bladder cancer	2.48e-05	0.000467	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—SLC19A1—urinary bladder cancer	2.47e-05	0.000464	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—UGT2B7—urinary bladder cancer	2.43e-05	0.000457	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—LIG1—urinary bladder cancer	2.4e-05	0.000452	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—PRSS3—urinary bladder cancer	2.4e-05	0.000452	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	2.36e-05	0.000444	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GSTP1—urinary bladder cancer	2.31e-05	0.000435	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTZ1—urinary bladder cancer	2.29e-05	0.000431	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—HDAC4—urinary bladder cancer	2.29e-05	0.000431	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Selenium Micronutrient Network—TNF—urinary bladder cancer	2.24e-05	0.000421	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—NQO1—urinary bladder cancer	2.22e-05	0.000417	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—CYP4B1—urinary bladder cancer	2.19e-05	0.000412	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.000412	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTO2—urinary bladder cancer	2.17e-05	0.000409	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NAT1—urinary bladder cancer	2.17e-05	0.000409	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—NRF2 pathway—GSTP1—urinary bladder cancer	2.17e-05	0.000409	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—TYMS—urinary bladder cancer	2.15e-05	0.000404	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GSTM1—urinary bladder cancer	2.12e-05	0.0004	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—NCOR1—urinary bladder cancer	2.12e-05	0.0004	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—TYMP—urinary bladder cancer	2.12e-05	0.0004	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—SLC19A1—urinary bladder cancer	2.07e-05	0.000389	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—GPX1—urinary bladder cancer	2.03e-05	0.000383	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—NCOR1—urinary bladder cancer	2.03e-05	0.000381	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000381	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000381	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—SLC19A1—urinary bladder cancer	2.02e-05	0.00038	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—PRSS3—urinary bladder cancer	2.01e-05	0.000379	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—ERCC2—urinary bladder cancer	2e-05	0.000376	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—NRF2 pathway—GSTM1—urinary bladder cancer	2e-05	0.000375	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—UGT2B7—urinary bladder cancer	1.99e-05	0.000374	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—PRSS3—urinary bladder cancer	1.97e-05	0.00037	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.00037	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NAT2—urinary bladder cancer	1.92e-05	0.000361	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—ERCC2—urinary bladder cancer	1.91e-05	0.000359	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—HDAC4—urinary bladder cancer	1.88e-05	0.000353	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—MTHFR—urinary bladder cancer	1.88e-05	0.000353	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GSTP1—urinary bladder cancer	1.85e-05	0.000348	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—ENO2—urinary bladder cancer	1.83e-05	0.000345	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—LIG1—urinary bladder cancer	1.82e-05	0.000343	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—MTHFR—urinary bladder cancer	1.79e-05	0.000337	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—CYP4B1—urinary bladder cancer	1.79e-05	0.000337	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—TERT—urinary bladder cancer	1.79e-05	0.000336	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—RBX1—urinary bladder cancer	1.74e-05	0.000327	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—TYMS—urinary bladder cancer	1.72e-05	0.000323	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	1.71e-05	0.000321	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GSTM1—urinary bladder cancer	1.7e-05	0.000319	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—NCOR1—urinary bladder cancer	1.7e-05	0.000319	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—SLC19A1—urinary bladder cancer	1.69e-05	0.000318	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—RRM2—urinary bladder cancer	1.66e-05	0.000312	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—PRSS3—urinary bladder cancer	1.65e-05	0.00031	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—FGFR3—urinary bladder cancer	1.64e-05	0.000308	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—NQO1—urinary bladder cancer	1.63e-05	0.000307	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—GPX1—urinary bladder cancer	1.63e-05	0.000306	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—TYMP—urinary bladder cancer	1.61e-05	0.000303	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—ERCC2—urinary bladder cancer	1.6e-05	0.0003	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—JAG1—urinary bladder cancer	1.56e-05	0.000293	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—HPGDS—urinary bladder cancer	1.54e-05	0.000289	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—ENO2—urinary bladder cancer	1.54e-05	0.000289	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—PPARG—urinary bladder cancer	1.52e-05	0.000286	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—MTHFR—urinary bladder cancer	1.5e-05	0.000282	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—LIG1—urinary bladder cancer	1.49e-05	0.000281	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTT1—urinary bladder cancer	1.49e-05	0.00028	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—CREBBP—urinary bladder cancer	1.46e-05	0.000275	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NAT2—urinary bladder cancer	1.46e-05	0.000274	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—CREBBP—urinary bladder cancer	1.4e-05	0.000263	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.39e-05	0.000262	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—ENO2—urinary bladder cancer	1.39e-05	0.000261	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.000256	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—TYMP—urinary bladder cancer	1.32e-05	0.000248	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—RBX1—urinary bladder cancer	1.32e-05	0.000248	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000238	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—RHOA—urinary bladder cancer	1.26e-05	0.000238	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—RRM2—urinary bladder cancer	1.26e-05	0.000236	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000235	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000235	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NQO1—urinary bladder cancer	1.24e-05	0.000233	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—PPARG—urinary bladder cancer	1.22e-05	0.000229	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000225	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—PTGS2—urinary bladder cancer	1.2e-05	0.000225	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NAT2—urinary bladder cancer	1.19e-05	0.000224	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—JAG1—urinary bladder cancer	1.18e-05	0.000222	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000221	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—CREBBP—urinary bladder cancer	1.17e-05	0.00022	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—ERBB2—urinary bladder cancer	1.17e-05	0.00022	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—HPGDS—urinary bladder cancer	1.16e-05	0.000219	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—ENO2—urinary bladder cancer	1.16e-05	0.000219	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—PTGS2—urinary bladder cancer	1.14e-05	0.000215	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—ENO2—urinary bladder cancer	1.14e-05	0.000214	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—NCOR1—urinary bladder cancer	1.13e-05	0.000213	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTT1—urinary bladder cancer	1.13e-05	0.000212	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000208	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—RBX1—urinary bladder cancer	1.08e-05	0.000203	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—ERCC2—urinary bladder cancer	1.07e-05	0.0002	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—PTEN—urinary bladder cancer	1.04e-05	0.000196	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	0.000194	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—RRM2—urinary bladder cancer	1.03e-05	0.000193	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—MTHFR—urinary bladder cancer	1e-05	0.000188	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—CDKN1A—urinary bladder cancer	9.99e-06	0.000188	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—TERT—urinary bladder cancer	9.99e-06	0.000188	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—PTEN—urinary bladder cancer	9.97e-06	0.000188	CbGpPWpGaD
Tetrahydrofolic acid—FTCD—Metabolism—EP300—urinary bladder cancer	9.96e-06	0.000187	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—JAG1—urinary bladder cancer	9.65e-06	0.000182	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—TYMS—urinary bladder cancer	9.6e-06	0.000181	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—PTGS2—urinary bladder cancer	9.57e-06	0.00018	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—HPGDS—urinary bladder cancer	9.53e-06	0.000179	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—ENO2—urinary bladder cancer	9.53e-06	0.000179	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—EP300—urinary bladder cancer	9.51e-06	0.000179	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—NCOR1—urinary bladder cancer	9.49e-06	0.000178	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GSTM1—urinary bladder cancer	9.49e-06	0.000178	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.41e-06	0.000177	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NQO1—urinary bladder cancer	9.38e-06	0.000176	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—SRC—urinary bladder cancer	9.25e-06	0.000174	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTT1—urinary bladder cancer	9.24e-06	0.000174	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—FGFR3—urinary bladder cancer	9.16e-06	0.000172	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—GPX1—urinary bladder cancer	9.09e-06	0.000171	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—PPARG—urinary bladder cancer	8.97e-06	0.000169	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—ERCC2—urinary bladder cancer	8.92e-06	0.000168	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—CREBBP—urinary bladder cancer	8.62e-06	0.000162	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—NCOR1—urinary bladder cancer	8.59e-06	0.000161	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—MTHFR—urinary bladder cancer	8.39e-06	0.000158	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—PTEN—urinary bladder cancer	8.35e-06	0.000157	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—MYC—urinary bladder cancer	8.29e-06	0.000156	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—EGFR—urinary bladder cancer	8.1e-06	0.000152	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—ERCC2—urinary bladder cancer	8.07e-06	0.000152	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Metabolism—EP300—urinary bladder cancer	7.96e-06	0.00015	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTP1—urinary bladder cancer	7.83e-06	0.000147	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—CREBBP—urinary bladder cancer	7.8e-06	0.000147	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NQO1—urinary bladder cancer	7.68e-06	0.000144	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—KRAS—urinary bladder cancer	7.66e-06	0.000144	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—MTHFR—urinary bladder cancer	7.59e-06	0.000143	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—TERT—urinary bladder cancer	7.57e-06	0.000142	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—TYMS—urinary bladder cancer	7.27e-06	0.000137	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GSTM1—urinary bladder cancer	7.19e-06	0.000135	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—NCOR1—urinary bladder cancer	7.19e-06	0.000135	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—PTGS2—urinary bladder cancer	7.06e-06	0.000133	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—RHOA—urinary bladder cancer	7.06e-06	0.000133	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—NCOR1—urinary bladder cancer	7.03e-06	0.000132	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—FGFR3—urinary bladder cancer	6.94e-06	0.000131	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—GPX1—urinary bladder cancer	6.89e-06	0.00013	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—PPARG—urinary bladder cancer	6.8e-06	0.000128	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—ERCC2—urinary bladder cancer	6.76e-06	0.000127	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—ERCC2—urinary bladder cancer	6.61e-06	0.000124	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—CREBBP—urinary bladder cancer	6.53e-06	0.000123	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—ERBB2—urinary bladder cancer	6.53e-06	0.000123	CbGpPWpGaD
Tetrahydrofolic acid—MTHFD1—Disease—HRAS—urinary bladder cancer	6.51e-06	0.000122	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTP1—urinary bladder cancer	6.4e-06	0.00012	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—PTGS2—urinary bladder cancer	6.39e-06	0.00012	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—MTHFR—urinary bladder cancer	6.36e-06	0.00012	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—TERT—urinary bladder cancer	6.19e-06	0.000116	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—PTEN—urinary bladder cancer	6.16e-06	0.000116	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—TYMS—urinary bladder cancer	5.95e-06	0.000112	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—CREBBP—urinary bladder cancer	5.91e-06	0.000111	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—NCOR1—urinary bladder cancer	5.89e-06	0.000111	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GSTM1—urinary bladder cancer	5.89e-06	0.000111	CbGpPWpGaD
Tetrahydrofolic acid—ATIC—Metabolism—EP300—urinary bladder cancer	5.87e-06	0.00011	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—FGFR3—urinary bladder cancer	5.68e-06	0.000107	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—GPX1—urinary bladder cancer	5.64e-06	0.000106	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—CDKN1A—urinary bladder cancer	5.58e-06	0.000105	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—PTEN—urinary bladder cancer	5.57e-06	0.000105	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—ERCC2—urinary bladder cancer	5.53e-06	0.000104	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—PTGS2—urinary bladder cancer	5.35e-06	0.000101	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—RHOA—urinary bladder cancer	5.35e-06	0.000101	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—EP300—urinary bladder cancer	5.31e-06	9.99e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—SRC—urinary bladder cancer	5.17e-06	9.72e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—PPARG—urinary bladder cancer	5.15e-06	9.69e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—CREBBP—urinary bladder cancer	4.95e-06	9.31e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—ERBB2—urinary bladder cancer	4.95e-06	9.31e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—PTGS2—urinary bladder cancer	4.84e-06	9.1e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—CREBBP—urinary bladder cancer	4.84e-06	9.1e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—PTEN—urinary bladder cancer	4.67e-06	8.77e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—MYC—urinary bladder cancer	4.63e-06	8.71e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—EGFR—urinary bladder cancer	4.53e-06	8.52e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Metabolism—EP300—urinary bladder cancer	4.45e-06	8.37e-05	CbGpPWpGaD
Tetrahydrofolic acid—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.4e-06	8.28e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—RHOA—urinary bladder cancer	4.38e-06	8.23e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—KRAS—urinary bladder cancer	4.28e-06	8.04e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—CDKN1A—urinary bladder cancer	4.23e-06	7.96e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—PTEN—urinary bladder cancer	4.22e-06	7.94e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—PPARG—urinary bladder cancer	4.22e-06	7.93e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—PTGS2—urinary bladder cancer	4.05e-06	7.62e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—CREBBP—urinary bladder cancer	4.05e-06	7.62e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—ERBB2—urinary bladder cancer	4.05e-06	7.62e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—EP300—urinary bladder cancer	4.03e-06	7.57e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—PTGS2—urinary bladder cancer	3.96e-06	7.45e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—SRC—urinary bladder cancer	3.92e-06	7.36e-05	CbGpPWpGaD
Tetrahydrofolic acid—SHMT1—Disease—HRAS—urinary bladder cancer	3.64e-06	6.84e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—PTEN—urinary bladder cancer	3.54e-06	6.65e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—MYC—urinary bladder cancer	3.51e-06	6.6e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—CDKN1A—urinary bladder cancer	3.46e-06	6.51e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—PTEN—urinary bladder cancer	3.46e-06	6.5e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—EGFR—urinary bladder cancer	3.43e-06	6.45e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Metabolism—EP300—urinary bladder cancer	3.37e-06	6.34e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—PTGS2—urinary bladder cancer	3.32e-06	6.24e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—EP300—urinary bladder cancer	3.3e-06	6.2e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—KRAS—urinary bladder cancer	3.24e-06	6.1e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—SRC—urinary bladder cancer	3.2e-06	6.03e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—PTEN—urinary bladder cancer	2.89e-06	5.44e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—MYC—urinary bladder cancer	2.87e-06	5.4e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—EGFR—urinary bladder cancer	2.81e-06	5.28e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Metabolism—EP300—urinary bladder cancer	2.76e-06	5.19e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTR—Disease—HRAS—urinary bladder cancer	2.76e-06	5.18e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—KRAS—urinary bladder cancer	2.65e-06	4.99e-05	CbGpPWpGaD
Tetrahydrofolic acid—MTHFR—Disease—HRAS—urinary bladder cancer	2.26e-06	4.24e-05	CbGpPWpGaD
